Cargando…

Advances in epigenetic therapeutics with focus on solid tumors

Epigenetic (“above genetics”) modifications can alter the gene expression without altering the DNA sequence. Aberrant epigenetic regulations in cancer include DNA methylation, histone methylation, histone acetylation, non-coding RNA, and mRNA methylation. Epigenetic-targeted agents have demonstrated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jin, Ning, George, Tiffany L., Otterson, Gregory A., Verschraegen, Claire, Wen, Haitao, Carbone, David, Herman, James, Bertino, Erin M., He, Kai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056722/ https://www.ncbi.nlm.nih.gov/pubmed/33879235 http://dx.doi.org/10.1186/s13148-021-01069-7

Ejemplares similares

Change in neutrophil to lymphocyte ratio during immunotherapy treatment is a non-linear predictor of patient outcomes in advanced cancers
por: Li, Mingjia, et al.
Publicado: (2019)

Incidence, Risk Factors, and Effect on Survival of Immune-related Adverse Events in Patients With None–Small-cell Lung Cancer
por: Owen, Dwight H., et al.
Publicado: (2018)

Phase 1 dose-escalation study evaluating the safety, pharmacokinetics, and clinical activity of OBI-3424 in patients with advanced or metastatic solid tumors
por: Tsimberidou, Apostolia Maria, et al.
Publicado: (2023)

Advances in Epigenetic Cancer Therapeutics
por: Hillyar, Christopher, et al.
Publicado: (2020)

A Phase I Protocol of Hydralazine and Valproic Acid in Advanced, Previously Treated Solid Cancers
por: Bauman, Julie, et al.
Publicado: (2014)

Epigenetic targeting drugs potentiate chemotherapeutic effects in solid tumor therapy
por: Li, Jingjing, et al.
Publicado: (2017)

Recent Advances in Immunotherapy for Patients with Head and Neck Cutaneous Squamous Cell Carcinoma
por: Khorasanchi, Adam, et al.
Publicado: (2022)

Identifying patterns of care for elderly patients with non-surgically treated stage III non-small cell lung cancer: an analysis of the national cancer database
por: Miller, Eric D, et al.
Publicado: (2018)

Long-term avelumab in advanced non-small-cell lung cancer: summaries and post hoc analyses from JAVELIN Solid Tumor
por: Hrinczenko, Borys, et al.
Publicado: (2022)

Case report: The power of immunotherapy in advanced cutaneous squamous cell carcinoma
por: Brockwell, Maximilian, et al.
Publicado: (2023)

Molecular pathways and therapeutic targets in lung cancer
por: Shtivelman, Emma, et al.
Publicado: (2014)

Epigenetic versus Genetic Deregulation of the KEAP1/NRF2 Axis in Solid Tumors: Focus on Methylation and Noncoding RNAs
por: Fabrizio, F. P., et al.
Publicado: (2018)

Potential of epigenetic therapies in the management of solid tumors
por: Valdespino, Victor, et al.
Publicado: (2015)

The monoclonal antibody to cytotoxic T lymphocyte antigen 4, ipilimumab, in the treatment of melanoma
por: Verschraegen, Claire
Publicado: (2012)

Tumor Immune Microenvironment in Lymphoma: Focus on Epigenetics
por: García-Domínguez, Daniel J., et al.
Publicado: (2022)

Impact of lack of surgery on outcomes in elderly women with nonmetastatic breast cancer—A surveillance, epidemiology, and end results 18 population based study
por: Yin, Ming, et al.
Publicado: (2020)

Recent advances in epigenetic anticancer therapeutics and future perspectives
por: Ren, Liwen, et al.
Publicado: (2023)

Emerging biomarkers for checkpoint inhibitors in thymic epithelial tumors
por: Owen, Dwight H., et al.
Publicado: (2019)

Epigenetic Approaches to Overcome Fluoropyrimidines Resistance in Solid Tumors
por: Grumetti, Laura, et al.
Publicado: (2022)

Epigenetic Therapy for Solid Tumors: Highlighting the Impact of Tumor Hypoxia
por: Ramachandran, Shaliny, et al.
Publicado: (2015)

Phase I Dose Escalation Study of Sodium Stibogluconate (SSG), a Protein Tyrosine Phosphatase Inhibitor, Combined with Interferon Alpha for Patients with Solid Tumors
por: Naing, Aung, et al.
Publicado: (2011)

Hepatocellular carcinoma: Therapeutic advances in signaling, epigenetic and immune targets
por: Neureiter, Daniel, et al.
Publicado: (2019)

Immune Checkpoints in Pediatric Solid Tumors: Targetable Pathways for Advanced Therapeutic Purposes
por: Cocco, Claudia, et al.
Publicado: (2021)

Epigenetics of Most Aggressive Solid Tumors: Pathways, Targets and Treatments
por: Martinez-Useros, Javier, et al.
Publicado: (2021)

Epigenetic modifications as therapeutic targets in atherosclerosis: a focus on DNA methylation and non-coding RNAs
por: Sum, Hashum, et al.
Publicado: (2023)

Translating epigenetics into clinic: focus on lupus
por: Wang, Zijun, et al.
Publicado: (2017)

In this issue of Epigenetics: Special Focus on Non-coding RNAs in Epigenetic Regulation
por: Slack, Frank J
Publicado: (2014)

Recent developments in epigenetic cancer therapeutics: clinical advancement and emerging trends
por: Nepali, Kunal, et al.
Publicado: (2021)

NAD- and NADPH-Contributing Enzymes as Therapeutic Targets in Cancer: An Overview
por: Pramono, Alvinsyah Adhityo, et al.
Publicado: (2020)

Fanconi Anemia Repair Pathway Dysfunction, a Potential Therapeutic Target in Lung Cancer
por: Duan, Wenrui, et al.
Publicado: (2014)

Molecular Targets for Novel Therapeutics in Pediatric Fusion-Positive Non-CNS Solid Tumors
por: Chang, Wen-I, et al.
Publicado: (2022)

Drug Nanocrystals: Focus on Brain Delivery from Therapeutic to Diagnostic Applications
por: Zingale, Elide, et al.
Publicado: (2022)

Inferring the role of the microbiome on survival in patients treated with immune checkpoint inhibitors: causal modeling, timing, and classes of concomitant medications
por: Spakowicz, Daniel, et al.
Publicado: (2020)

Hereditary Ataxia: A Focus on Heme Metabolism and Fe-S Cluster Biogenesis
por: Chiabrando, Deborah, et al.
Publicado: (2020)

Epigenetics of Indolent Lymphoma and How It Drives Novel Therapeutic Approaches—Focus on EZH2-Targeted Drugs
por: Longley, Jemma, et al.
Publicado: (2021)

Epigenetic regulation and therapeutic targets in the tumor microenvironment
por: Xie, Zhuojun, et al.
Publicado: (2023)

Integrins regulate stemness in solid tumor: an emerging therapeutic target
por: Xiong, Jiangling, et al.
Publicado: (2021)

CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances
por: Maalej, Karama Makni, et al.
Publicado: (2023)

Focus On: Epigenetics and Fetal Alcohol Spectrum Disorders
por: Kobor, Michael S., et al.
Publicado: (2011)

The Biochemistry and Epigenetics of Epilepsy: Focus on Adenosine and Glycine
por: Boison, Detlev
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_l1bjuvs70ikilocgncv8bgf90e